ATC代码 (N02)
維基媒體列表條目
(重定向自ATC code N02)
ATC代码N02(镇痛药)是解剖学治疗学及化学分类系统的一个药物分组,这是由世界卫生组织药物统计方法整合中心(The WHO Collaborating Centre for Drug Statistics Methodology)所制定的药品及其它医用产品的官方分类系统。分组N02是N神经系统的一部分。[1]
ATC |
---|
N 神经系统 |
N01 麻醉剂(Anesthetics) |
N02 止痛药(Analgesics) |
N03 抗癫痫药(Antiepileptics) |
N04 抗帕金森氏药(Anti-parkinson drugs) |
N05 精神抑制药(Psycholeptics) |
N06 精神兴奋药(Psychoanaleptics) |
N07 其他神经系统药品(Other nervous system drugs) |
ATCvet专用 |
QN51 动物安乐死用品(Products for animal euthanasia) |
|
兽用代码(ATCvet码)可以在人用ATC代码前加Q字母:QN02等[2]。没有相应人用ATC代码的ATCvet在以下列表中通过前置Q字母表示。
国家ATC分类可能包括列表中没有的其它分类,列表为世界卫生组织(WHO)版本。
N02A 阿片碱类(Opioids)
N02AA 天然阿片生物碱类(Natural opium alkaloids)
- N02AA01 吗啡(Morphine)
- N02AA02 阿片(Opium)
- N02AA03 二氢吗啡酮(Hydromorphone)
- N02AA04 尼可吗啡(Nicomorphine)
- N02AA05 羟考酮(Oxycodone)
- N02AA08 双氢可待因(Dihydrocodeine)
- N02AA09 二醋吗啡(Diamorphine)
- N02AA10 阿片全碱(Papaveretum)
- N02AA51 吗啡,复方(Morphine, combinations)
- N02AA55 羟考酮,复方(Oxycodone, combinations)
- N02AA58 双氢可待因,复方(Dihydrocodeine, combinations)
- N02AA59 可待因,与非精神阻断剂的复方(Codeine, combinations excluding psycholeptics)
- N02AA79 可待因,与精神阻断剂的复方(Codeine, combinations with psycholeptics)
N02AB 苯哌啶衍生物(Phenylpiperidine derivatives)
- N02AB01 凯托米酮(Ketobemidone)
- N02AB02 哌替啶(Pethidine)
- N02AB03 芬太尼(Fentanyl)
- N02AB52 哌替啶,与非安定药的复方(Pethidine, combinations excluding psycholeptics)
- QN02AB53 芬太尼,与非安定药的复方(Fentanyl, combinations excluding psycholeptics)
- N02AB72 哌替啶,与安定药的复方(Pethidine, combinations with psycholeptics)
- N02AB60 哌替啶,混合(Pethidine, mixed)
- QN02AB73 芬太尼,与安定药的复方(Fentanyl, combinations with psycholeptics)
N02AC 二苯丙胺衍生物(Diphenylpropylamine derivatives)
- N02AC01 右吗拉胺(Dextromoramide)
- N02AC03 哌腈米特(Piritramide)
- N02AC04 右丙氧芬(Dextropropoxyphene)
- N02AC05 贝齐米特(Bezitramide)
- N02AC52 美沙酮,与非安定药的复方(Methadone, combinations excluding psycholeptics)
- N02AC54 右丙氧芬,与非安定药的复方(Dextropropoxyphene, combinations excluding psycholeptics)
- N02AC74 右丙氧芬,与安定药的复方(Dextropropoxyphene, combinations with psycholeptics)
N02AD 苯并啡烷衍生物(Benzomorphan derivatives)
N02AE 东罂粟碱衍生物(Oripavine derivatives)
- N02AE01 丁丙诺啡(Buprenorphine)
- QN02AE90 埃托啡(Etorphine)
- QN02AE99 东罂粟碱衍生物,复方(Oripavine derivatives, combinations)
N02AF 吗啡烷衍生物(Morphinan derivatives)
N02AG 阿片生物碱类与解痉药的复方(Opioids in combination with antispasmodics)
- N02AG01 吗啡和解痉药(Morphine and antispasmodics)
- N02AG02 凯托米酮和解痉药(Ketobemidone and antispasmodics)
- N02AG03 哌替啶和解痉药(Pethidine and antispasmodics)
- N02AG04二氢吗啡酮和解痉药(Hydromorphone and antispasmodics)
N02AX 其它生物碱类(Other opioids)
N02B 其它解热镇痛药(Other analgesics and antipyretics)
N02BA 水杨酸及其衍生物(Salicylic acid and derivatives)
- N02BA01 乙酰水杨酸(Acetylsalicylic acid)
- N02BA02 阿洛普令(Aloxiprin)
- N02BA03 水杨酸胆碱(Choline salicylate)
- N02BA04 水杨酸钠(Sodium salicylate)
- N02BA05 水杨酰胺(Salicylamide)
- N02BA06 双水杨酯(Salsalate)
- N02BA07 乙水杨胺(Ethenzamide)
- N02BA08 水杨吗啉(Morpholine salicylate)
- N02BA09 地匹乙酯(Dipyrocetyl)
- N02BA10 贝诺酯(Benorilate)
- N02BA11 二氟尼柳(Diflunisal)
- N02BA12 水杨酸钾(Potassium salicylate)
- N02BA14 呱西替柳(Guacetisal)
- N02BA15 卡巴匹林钙(Carbasalate calcium)
- N02BA16 水杨酸咪唑(Imidazole salicylate)
- N02BA51 乙酰水杨酸,与非安定药的复方(Acetylsalicylic acid, combinations excluding psycholeptics)
- N02BA55 水杨酰胺,与非安定药的复方(Salicylamide, combinations excluding psycholeptics)
- N02BA57 乙水杨胺,与非安定药的复方(Ethenzamide, combinations excluding psycholeptics)
- N02BA59 地匹乙酯,与非安定药的复方(Dipyrocetyl, combinations excluding psycholeptics)
- N02BA65 卡巴匹林钙,与非安定药的复方(Carbasalate calcium combinations excluding psycholeptics)
- N02BA71 乙酰水杨酸,与安定药的复方(Acetylsalicylic acid, combinations with psycholeptics)
- N02BA75 水杨酰胺,与安定药的复方(Salicylamide, combinations with psycholeptics)
- N02BA77 乙水杨胺,与安定药的复方(Ethenzamide, combinations with psycholeptics)
- N02BA79 地匹乙酯,与安定药的复方(Dipyrocetyl, combinations with psycholeptics)
N02BB 吡唑酮类(Pyrazolones)
- N02BB01 安替比林(Phenazone)
- N02BB02 安乃近(Metamizole)
- N02BB03 氨基比林(Aminophenazone)
- N02BB04 异丙安替比林(Propyphenazone)
- N02BB05 尼芬那宗(Nifenazone)
- N02BB51 安替比林,与非安定药的复方(Phenazone, combinations excluding psycholeptics)
- N02BB52 安乃近,与非安定药的复方(Metamizole sodium, combinations excluding psycholeptics)
- N02BB53 氨基比林,与非安定药的复方(Aminophenazone, combinations excluding psycholeptics)
- N02BB54 异丙安替比林,与非安定药的复方(Propyphenazone, combinations excluding psycholeptics)
- N02BB71 安替比林,与安定药的复方(Phenazone, combinations with psycholeptics)
- N02BB72 安乃近,与安定药的复方(Metamizole sodium, combinations with psycholeptics)
- N02BB73 氨基比林,与安定药的复方(Aminophenazone, combinations with psycholeptics)
- N02BB74 异丙安替比林,与安定药的复方(Propyphenazone, combinations with psycholeptics)
N02BE 酰苯胺类(Anilides)
- N02BE01 对乙酰氨基酚(Paracetamol)
- N02BE03 非那西汀(Phenacetin)
- N02BE04 布西汀(Bucetin)
- N02BE05 丙帕他莫(Propacetamol)
- N02BE51 对乙酰氨基酚,与非安定药的复方(Paracetamol, combinations excluding psycholeptics)
- N02BE53 非那西汀,与非安定药的复方(Phenacetin, combinations excluding psycholeptics)
- N02BE54 布西汀,与非安定药的复方(Bucetin, combinations excluding psycholeptics)
- N02BE71 对乙酰氨基酚,与安定药的复方(Paracetamol, combinations with psycholeptics)
- N02BE73 非那西汀,与安定药的复方(Phenacetin, combinations with psycholeptics)
- N02BE74 布西汀,与安定药的复方(Bucetin, combinations with psycholeptics)
N02BG 其它解热镇痛药(Other analgesics and antipyretics)
N02C 抗偏头痛药(Antimigraine preparations)
N02CA 麦角生物碱类(Ergot alkaloids)
- N02CA01 双氢麦角胺(Dihydroergotamine)
- N02CA02 麦角胺(Ergotamine)
- N02CA04 美西麦角(Methysergide)
- N02CA07 麦角乙脲(Lisuride)
- N02CA51 双氢麦角胺,复方(Dihydroergotamine, combinations)
- N02CA52 麦角胺,与非安定药的复方(Ergotamine, combinations excluding psycholeptics)
- N02CA72 麦角胺,与安定药的复方(Ergotamine, combinations with psycholeptics)
N02CB 皮质甾体激素衍生物类(Corticosteroid derivatives)
- N02CB01 氟美烯酮(Flumedroxone)
N02CC 选择性5-羟色胺(5HT1)促效药(Selective serotonin (5-HT1) agonists)
- N02CC01 舒马曲坦(Sumatriptan)
- N02CC02 那拉曲坦(Naratriptan)
- N02CC03 佐米曲坦(Zolmitriptan)
- N02CC04 利扎曲坦(Rizatriptan)
- N02CC05 阿莫曲坦(Almotriptan)
- N02CC06 依利曲坦(Eletriptan)
- N02CC07 氟罗曲坦(Frovatriptan)
N02CX 其它抗偏头痛药(Other antimigraine preparations)
- N02CX01 苯噻啶(Pizotifen)
- N02CX02 可乐定(Clonidine)
- N02CX03 异丙佐罗(Iprazochrome)
- N02CX05 二甲替嗪(Dimetotiazine)
- N02CX06 奥昔托隆(Oxetorone)
参考文献
- ^ ATC Index. WHO Collaborating Centre for Drug Statistics Methodology.
- ^ ATCvet Index. WHO Collaborating Centre for Drug Statistics Methodology.